High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab.

Mandal, M; Mazza, M; Esquinas, A M

Mandal, M; Mazza, M; Esquinas, A M.

Mandal M; Department of Anesthesiology, Institute of Post Graduate Medical Education & Research, 244, Acharya Jagadish Chandra Bose Road, Kolkata 700 020, India.
Mazza M; UOC Pneumologia Semintensiva COVID, A.O. Sant'Anna e San Sebastiano, di Rilievo Nazionale e alta Specializzazione, Via Ferdinando Palasciano, 81100 Caserta, Italy. Electronic address: dottmmazza@gmail.com.
Esquinas AM; Intensive Care Unit, Hospital Morales Mesenguer, Murcia, Spain.

Infect Dis Now ; 52(5): 324-325, 2022 08.

Article in English | MEDLINE | ID: covidwho-1821254

Subject(s)

COVID-19 Drug Treatment; Antibodies, Monoclonal, Humanized/therapeutic use; Humans; Oxygen/therapeutic use

Keywords

COVID-19 pneumonia; High-flow nasal oxygen; Tocilizumab

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Infect Dis Now Year: 2022 Document Type: Article Affiliation country: J.idnow.2022.04.008

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google